Insider · CIK 0001900910
Prem S Shah
Files at CVS (CVS HEALTH Corp). First filing Feb 16, 2024, latest Feb 16, 2024.
In brief
Prem S Shah files SEC Form 4 as officer at CVS (CVS HEALTH Corp). Since Feb 16, 2024, Prem S Shah has reported 0 open-market buys worth $0 and 1 open-market sell worth $2.3M, the latest filed on Feb 16, 2024.
A track record needs three past buys with six months of prices behind them; Prem S Shah has 0, so none is measured yet.
The newest scored trade: sold $2.3M of CVS on Feb 16, 2024, filed Feb 16, 2024, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVS: CVS HEALTH Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | CVSsell CVS HEALTH Corp | $2.3M 29,473 shares | -43% | +20% from low-10% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 16, 2024 | CVS CVS HEALTH CORPORATION | 29,473 0.00% of outstanding | $2.3M | Feb 16, 2024 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +25,062 | $71.82 | $1.8M | 62,852 | Apr 2, 2026 |
| Apr 1, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -1,484 | $72.49 | $108k | 64,356 | Apr 2, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +161,676 | $71.82 | $12M | 161,676 | Apr 2, 2026 |
| Jan 1, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -247 | $80.13 | $20k | 61,509 | Jan 5, 2026 |
| Aug 31, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -6,995 | $73.15 | $512k | 60,632 | Sep 2, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -1,308 | $67.98 | $89k | 47,251 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +26,478 | $67.98 | $1.8M | 58,166 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +112,289 | $67.98 | $7.6M | 112,289 | Apr 3, 2025 |
| Mar 17, 2025 | CVS CVS HEALTH Corp | MOption exercise Common Stock | +846 | $62.21 | $53k | 43,190 | Mar 18, 2025 |
| Mar 17, 2025 | CVS CVS HEALTH Corp | MOption exercise Stock Optionderivative | -846 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Nov 30, 2024 | CVS CVS HEALTH Corp | AGrant or award Premium Stock Optionderivative | +746,268 | $71.82 | $54M | 746,268 | Dec 3, 2024 |
| Feb 26, 2024 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -261 | $76.43 | $20k | 43,185 | Feb 28, 2024 |
| Feb 16, 2024 | CVS CVS HEALTH Corp | SOpen-market sale Common Stock | -29,473 | $76.95 | $2.3M | 39,765 | Feb 16, 2024 |
| Feb 12, 2024 | CVS CVS HEALTH Corp | AGrant or award Common Stock | +13,313 | $0.00 | $0 | 69,238 | Feb 14, 2024 |
Questions about Prem S Shah
Answered from the filings on this page, as of the latest one.
Is Prem S Shah buying or selling?
Not in the last 12 months. Prem S Shah's latest open-market trade on SEC Form 4 was sold $2.3M of CVS on Feb 16, 2024.
How did Prem S Shah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Prem S Shah has 0.
Where does Prem S Shah file Form 4?
Prem S Shah has filed Form 4 at CVS (CVS HEALTH Corp) as EVP and Pres-Pharm, Consumer W. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.